Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Trial of Functional Bowel Disorders
NCT00006157Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 1996
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial of desipramine in functional bowel disorder (FBD), irritable bowel syndrome (IBS), constipation and 1 more (3 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Standardized abdominal pain, stool form and frequency at 1 year. Started Jul 1996; status: completed.
02
Drugs
desipramine
03
Conditions
functional bowel disorder (FBD)irritable bowel syndrome (IBS)constipationabdominal pain
Beyond the preview
Go deeper on NCT00006157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006157.